205 related articles for article (PubMed ID: 16266908)
1. Rituximab in patients with mucosal-associated lymphoid tissue-type lymphoma of the ocular adnexa.
Ferreri AJ; Ponzoni M; Martinelli G; Muti G; Guidoboni M; Dolcetti R; Doglioni C
Haematologica; 2005 Nov; 90(11):1578-9. PubMed ID: 16266908
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients.
Uno T; Isobe K; Shikama N; Nishikawa A; Oguchi M; Ueno N; Itami J; Ohnishi H; Mikata A; Ito H
Cancer; 2003 Aug; 98(4):865-71. PubMed ID: 12910532
[TBL] [Abstract][Full Text] [Related]
3. [Extranodal marginal zone lymphoma of the ocular adnexa].
Møller A; Specht L; Toft PB; Sjø LD
Ugeskr Laeger; 2008 Nov; 170(45):3660-3. PubMed ID: 18986616
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.
Cho EY; Han JJ; Ree HJ; Ko YH; Kang YK; Ahn HS; Ahn SD; Park CJ; Huh J
Am J Hematol; 2003 Jun; 73(2):87-96. PubMed ID: 12749009
[TBL] [Abstract][Full Text] [Related]
5. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.
Raderer M; Streubel B; Woehrer S; Puespoek A; Jaeger U; Formanek M; Chott A
Clin Cancer Res; 2005 May; 11(9):3349-52. PubMed ID: 15867234
[TBL] [Abstract][Full Text] [Related]
6. [Gastric relapse of stage I ocular adnexal mucosa-associated lymphoid tissue lymphoma].
Sato T; Takimoto R; Iyama S; Ono K; Tanaka S; Araki N; Nishiie K; Murase K; Sato Y; Kobune M; Matsunaga T; Kato J; Niitsu Y
Rinsho Ketsueki; 2007 Jan; 48(1):56-60. PubMed ID: 17313077
[TBL] [Abstract][Full Text] [Related]
7. Lymphoma of the ocular adnexa: A study of 353 cases.
Ferry JA; Fung CY; Zukerberg L; Lucarelli MJ; Hasserjian RP; Preffer FI; Harris NL
Am J Surg Pathol; 2007 Feb; 31(2):170-84. PubMed ID: 17255761
[TBL] [Abstract][Full Text] [Related]
8. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
[TBL] [Abstract][Full Text] [Related]
9. Use of rituximab for periocular and intraocular mucosa-associated lymphoid tissue lymphoma.
Shetty RK; Adams BH; Tun HW; Runyan BR; Menke DM; Broderick DF
Ocul Immunol Inflamm; 2010 Apr; 18(2):110-2. PubMed ID: 20370339
[TBL] [Abstract][Full Text] [Related]
10. Rituximab and chlorambucil as first-line treatment for low-grade ocular adnexal lymphomas.
Rigacci L; Nassi L; Puccioni M; Mappa S; Polito E; Dal Pozzo S; Alterini R; Carrai V; Puccini B; Bosi A
Ann Hematol; 2007 Aug; 86(8):565-8. PubMed ID: 17483948
[TBL] [Abstract][Full Text] [Related]
11. Ophthalmic lymphoma: epidemiology and pathogenesis.
Sjö LD
Acta Ophthalmol; 2009 Feb; 87 Thesis 1():1-20. PubMed ID: 19178392
[TBL] [Abstract][Full Text] [Related]
12. BCL10 expression in ocular adnexal lymphomas.
Vejabhuti C; Harris GJ; Erickson BA; Nishino H; Chevez-Barrios P; Chang CC
Am J Ophthalmol; 2005 Nov; 140(5):836-843. PubMed ID: 16310461
[TBL] [Abstract][Full Text] [Related]
13. Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience.
Vargas RL; Fallone E; Felgar RE; Friedberg JW; Arbini AA; Andersen AA; Rothberg PG
Leuk Res; 2006 May; 30(5):547-51. PubMed ID: 16246419
[TBL] [Abstract][Full Text] [Related]
14. Lacrimal gland extranodal marginal zone B-cell lymphoma of MALT-type.
Kao SC; Kau HC; Tsai CC; Tsay SH; Yang CF; Wu JS; Hsu WM
Am J Ophthalmol; 2007 Feb; 143(2):311-316. PubMed ID: 17184716
[TBL] [Abstract][Full Text] [Related]
15. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.
Ferreri AJ; Ponzoni M; Guidoboni M; Resti AG; Politi LS; Cortelazzo S; Demeter J; Zallio F; Palmas A; Muti G; Dognini GP; Pasini E; Lettini AA; Sacchetti F; De Conciliis C; Doglioni C; Dolcetti R
J Natl Cancer Inst; 2006 Oct; 98(19):1375-82. PubMed ID: 17018784
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD20 monoclonal antibody therapy in relapsed MALT lymphoma of the conjunctiva.
Nückel H; Meller D; Steuhl KP; Dührsen U
Eur J Haematol; 2004 Oct; 73(4):258-62. PubMed ID: 15347312
[TBL] [Abstract][Full Text] [Related]
18. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions.
Chanudet E; Zhou Y; Bacon CM; Wotherspoon AC; Müller-Hermelink HK; Adam P; Dong HY; de Jong D; Li Y; Wei R; Gong X; Wu Q; Ranaldi R; Goteri G; Pileri SA; Ye H; Hamoudi RA; Liu H; Radford J; Du MQ
J Pathol; 2006 Jul; 209(3):344-51. PubMed ID: 16583361
[TBL] [Abstract][Full Text] [Related]
19. Orbital marginal zone B-cell lymphoma of MALT: radiotherapy results and clinical behavior.
Suh CO; Shim SJ; Lee SW; Yang WI; Lee SY; Hahn JS
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):228-33. PubMed ID: 16503386
[TBL] [Abstract][Full Text] [Related]
20. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
Kerl K; Prins C; Saurat JH; French LE
Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
